Monoamine metabolites in cerebrospinal fluid during treatment with clonidine or alprenolol
- 1 January 1977
- journal article
- research article
- Published by Springer Nature in European Journal of Clinical Pharmacology
- Vol. 11 (2) , 125-128
- https://doi.org/10.1007/bf00562903
Abstract
Lumbar cerebrospinal fluid (CSF) concentrations of the major metabolites of noradrenaline (4-hydroxy-3-methoxyphenyl glycol, HMPG), serotonin (5-hydroxyindoleacetic acid) and dopamine (homovanillic acid) were measured before and during the administration of clonidine or alprenolol to hypertensive patients. The noradrenaline receptor stimulant clonidine significantly decreased the CSF level of HMPG, but there was no consistent change in the concentration of serotonin or dopamine metabolites. Patients on alprenolol showed no change in the levels of these metabolites in CSF.Keywords
This publication has 19 references indexed in Scilit:
- Effects of high dose propranolol treatment on dopamine and norepinephrine metabolism in regions of rat brainNeuroscience Letters, 1976
- Comparative studies on central factors contributing to the hypotensive action of propranolol, alprenolol, and their enantiomersCardiovascular Research, 1974
- Effects of phenoxybenzamine, aceperone and clonidine on the level of 3-methoxy-4-hydroxyphenylglycol (MOPEG) in rat brainJournal of Pharmacy and Pharmacology, 1974
- Quantitative determination of 4-hydroxy-3-methoxyphenyl glycol and its conjugates in cerebrospinal fluid by mass fragmentographyJournal of Chromatography A, 1973
- Gas-chromatographic determination of homovanillic acid in human cerebrospinal fluid by electron capture detection and by mass fragmentography with a deuterated internal standardAnalytical Chemistry, 1972
- Quantitative determination of 5-hydroxyindole-3-acetic acid in cerebrospinal fluid by gas chromatography-mass spectrometryAnalytical Chemistry, 1972
- Acid monoamine metabolites in human cerebrospinal fluid and their relations to age and sexNeuropharmacology, 1971
- Evidence for an α-sympathomimetic component in the effects of catapresan on vasomotor centres: Antagonism by piperoxaneEuropean Journal of Pharmacology, 1971
- Studies on catecholamines, renin and aldosterone following catapresan® (2-(2,6-dichlor-phenylamine)-2-imidazoline hydrochloride) in hypertensive patientsEuropean Journal of Pharmacology, 1970
- Acute hypotensive action of 2-(2,6-dichlorophenylamino)- 2-imidazoline hydrochloride (St 155) after infusion into the cat's vertebral arteryEuropean Journal of Pharmacology, 1967